Skip to main content
Premium Trial:

Request an Annual Quote

Oliver Liesenfeld

Inflammatix announced today that it has appointed Oliver Liesenfeld as chief medical officer. Liesenfeld comes to Inflammatix from Roche Diagnostics, where he has served as chief medical officer since 2012. Liesenfeld has over 25 years of industry and academic experience in the diagnostics field, with a focus on molecular diagnostics and infectious disease. Prior to Roche, Liesenfeld served as associate professor of medical microbioilogy and infection immunology at the Charite Medical School in Berlin, Germany, where his research focused on immune response to infections. 

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.